-
r37980778c78--0481298d3041dad3a95603fdc7462042
Mean SUCRA value, mean probability to be the best, and mean rank for each treatment based on total recovery, with the treatments in descending order of mean SUCRA. -
r37980778c78--35cd39301259e32224036ee6742db00a
Detailed analysis of randomized-controlled trials evaluating steroids in neonates. -
The effects of d-aspartic acid supplementation in resistance-trained men over...
ContextResearch on d-aspartic acid (DAA) has demonstrated increases in total testosterone levels in untrained men, however research in resistance-trained men demonstrated no... -
r37980778c78--8de4153ca91984adb0d1863a10029fea
Baseline correlates of participant retention at clinic visits and at the delivery visit. -
Classification of the placebo–controlled drug trials in neonates in ClinicalT...
Classification of the placebo–controlled drug trials in neonates in ClinicalTrials.gov (1999–2015) according to design and aim. -
Network meta-analysis for efficacy and safety of commonly prescribed medicati...
Network meta-analysis for efficacy and safety of commonly prescribed medications compared with methylphenidate. -
r37980778c78--8d5b27b67cfdd9da80e9433a89fb46d0
HIV-seropositive patients show high incidence of coronary heart disease and oxidative stress has been described as relevant key in atherosclerosis development. The aim of this... -
Patient characteristics at baseline.
║PC20 methacholine is expressed as geometric mean (standard deviation in doubling dose (DD)). ‡range 1 to 5 (higher scores indicate more dyspnea); †range 0 (best) to 100... -
r37980778c78--e1b6cdcac82936cfa35526be7c2335d5
Adverse events following azithromycin treatment among infants aged 1–5 months in communities randomized to azithromycin or placebo (N = 1,712). -
Characteristics of included trials.
PI, plaque index; GI, gingival index; PPD, probing pocket depth; CAL, clinical attachment loss; GR, gingival recession; BOP, bleeding on probing; NA, not available; CHX,... -
Flow chart presenting the selection of eligible studies.
Flow chart presenting the selection of eligible studies. -
Subgroup analysis according to the route of administration (injectable vs. or...
Subgroup analysis according to the route of administration (injectable vs. oral) of eligible disease modifying therapies for the treatment of relapsing-remitting multiple... -
Baseline clinical and biochemical characteristics between groups.
Data are showed as mean ± SD or mean (95% CI) according to normal or not-normal variable’s distribution. -
Outcome measures during Emergency Department stay.
Outcome measures during Emergency Department stay. -
The Effects of Intravenous Immunoglobulins in Women with Recurrent Miscarriag...
BackgroundImmunological disturbances are hypothesised to play a role in recurrent miscarriage (RM) and therefore intravenous immunoglubulins (IVIg) have been tested in RM...
